Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001852891 | SCV002274655 | uncertain significance | Tuberous sclerosis 2 | 2021-10-27 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature in individuals affected with TSC2-related conditions. This sequence change replaces glutamic acid, a(n) acidic and polar amino acid, with aspartic acid, a(n) acidic and polar amino acid, at codon 1087 of the TSC2 protein (p.Glu1087Asp). This variant is not present in population databases (gnomAD no frequency). ClinVar contains an entry for this variant (Variation ID: 49588). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt TSC2 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Tuberous sclerosis database |
RCV000042849 | SCV000066645 | not provided | Tuberous sclerosis syndrome | no assertion provided | curation |